Antitrust & Competition Policy Blog

Editor: D. Daniel Sokol
University of Florida
Levin College of Law

A Member of the Law Professor Blogs Network

Monday, September 27, 2010

Settlement Agreements and Patent Abuse in the Pharmaceutical Sector: An EU/US Comparison - 2010 Conference

Posted by D. Daniel Sokol

Speakers

Programme

Topics

Register

Sponsorship

The pharmaceutical sector continues to be one of the main focus areas for competition authorities throughout the world. This conference provides an update on the major developments affecting the sector including the General Court's recent judgment in the AstraZeneca case - the first judgment on dominance and abusive practices in the pharmaceutical sector.

Register

Speakers from the European Commission, law firms, economic consultancies and industry include:

Chairman: Stephen Kon, Partner, SJ Berwin LLP

  • Dominik Schnichels
    Head of Pharma Task Force, DG Competition, European Commission
  • Mike Walker
    Vice President, Charles River Associates
  • Marleen van Kerckhove
    Partner, Arnold & Porter LLP
  • Asim Varma
    Partner, Arnold & Porter LLP
  • James S. Venit
    Partner, Skadden Arps Slate Meagher & Flom LLP
  • David Rosenberg
    Vice President, Corporate IP Policy, GlaxoSmithKline
  • Cameron Firth
    Partner, SJ Berwin LLP
  • Gavin Robert
    Partner, Linklaters LLP
  • Jeffrey Schmidt
    Partner, Linklaters LLP
  • Mélanie Thill-Tayara
    Partner, Norton Rose
  • Jordi Faus
    Partner, Faus & Moliner Abogados
  • Thomas Wessely
    Partner, Freshfields Bruckhaus Deringer LLP

Register

Delegates will receive practical analysis and advice on:

  • AstraZeneca and the Commission's pharma policy
  • Market definition and dominance in the pharma sector following AstraZeneca - what does it mean for your company?
  • Unilateral conduct - when does it risk infringing antitrust rules? A view from the EU and the US
  • EU and US approach to settlement agreements
  • Roundtable: a follow up on the EU inquiry at national level

Download Programme Here

Conference Fees:

Standard


£650 + 21% TVA = £786.50

In-house lawyers and
Government Authorities


£550 + 21% TVA = £665.50

Register

Forthcoming GCR Conferences:

  • International Merger Control
    Major international conference to mark the 20th anniversary of the EU Merger Regulation
    28 & 29 September 2010, The Radisson Blu Royal Hotel, Brussels
  • 2010 Antitrust Litigation
    12 October 2010, The King's Fund, London
  • GCR's 2010 Competition Law Review
    In-depth analysis and debate on recent developments in competition law and policy 16 & 17 November 2010, The Conrad Hotel, Brussels
  • 2011 Antitrust Law Leaders Forum
    3 - 5 February 2011, Fontainebleau Hotel, Miami

Register

Cancellations

Cancellations must be received in writing. Cancellations received in writing two weeks before the conference will receive a refund less 10% + TVA. Cancellations received one week before will receive a refund less 50% + TVA. Cancellations received less than a week before the conference will not receive a refund. Substitute delegates are welcome at any time.

Unsubscribe

To unsubscribe from this briefing please email GCRconferences@GlobalCompetitionReview.com with 'unregister' in the subject field. If you have any queries regarding this briefing please contact us at GCRconferences@GlobalCompetitionReview.com.

Data protection

Any personal information provided by you will be held on a database and may be shared with other Law Business Research publications. If you do not want us to use your information for marketing purposes please contact GCRconferences@GlobalCompetitionReview.com.

Law Business Research Limited
87 Lancaster Road
London W11 1QQ
Registered in England and Wales number 03281866
Vat registration number GB 681 598586
TVA number pending

Speakers

Programme

Topics

Register

Sponsorship

http://lawprofessors.typepad.com/antitrustprof_blog/2010/09/settlement-agreements-and-patent-abuse-in-the-pharmaceutical-sector-an-euus-comparison-2010-conferen.html

| Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef0133f49f185a970b

Listed below are links to weblogs that reference Settlement Agreements and Patent Abuse in the Pharmaceutical Sector: An EU/US Comparison - 2010 Conference:

Comments

Post a comment